Law.com Subscribers SAVE 30%

Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.

<B><I>BREAKING NEWS:</b></i> <b>Merck Settles Vioxx Case for $950 Million</b>

Nate Raymond

Merck &amp; Co., Inc. became the latest healthcare company to strike a major settlement with the Justice Department on Nov. 22, agreeing to pay $950 million to resolve criminal and civil charges stemming from its marketing of the painkiller Vioxx.

Drug & Device News

ALM Staff & Law Journal Newsletters

News you may have missed.

Features

Verdicts

ALM Staff & Law Journal Newsletters

Analysis of recent key rulings.

Med Mal News

ALM Staff & Law Journal Newsletters

All the latest you need to know.

Features

Effective Use of Physician Assistants

Barry B. Cepelewicz & Richard J. Nealon

The use of P.A.s presents a number of medico-legal issues for a practice that must be considered, both by medical practitioners and their legal counsel. Failure to do so could result in increased liability exposure for the physician and the practice.

Features

Hospital-Acquired Infections Are on the Rise

Brandon Swartz

Last month, we discussed the rising incidence of deaths related to hospital-acquired infections. With the accompanying publicity of the dangers MRSA infection poses, it is not surprising that litigation in this area is also on the rise.

The Future of Medical Malpractice Claims in a 'Tele-World'

Elizabeth A. Syer

The pros and cons of "telemedicine," and what it means to the med mal practitioner.

Verdicts

ALM Staff & Law Journal Newsletters

In-depth analysis of an important ruling.

Features

Drug & Device News

ALM Staff & Law Journal Newsletters

Recent news of interest to you and your practice.

Med Mal News

ALM Staff & Law Journal Newsletters

A recent item of interest.

Need Help?

  1. Prefer an IP authenticated environment? Request a transition or call 800-756-8993.
  2. Need other assistance? email Customer Service or call 1-877-256-2472.

MOST POPULAR STORIES

  • Surveys in Patent Infringement Litigation: The Next Frontier
    Most experienced intellectual property attorneys understand the significant role surveys play in trademark infringement and other Lanham Act cases, but relatively few are likely to have considered the use of such research in patent infringement matters. That could soon change in light of the recent admission of a survey into evidence in <i>Applera Corporation, et al. v. MJ Research, Inc., et al.</i>, No. 3:98cv1201 (D. Conn. Aug. 26, 2005). The survey evidence, which showed that 96% of the defendant's customers used its products to perform a patented process, was admitted as evidence in support of a claim of inducement to infringe. The court admitted the survey into evidence over various objections by the defendant, who had argued that the inducement claim could not be proven without the survey.
    Read More ›